Dr. Trabulsi Edouard Trabulsi, M.D.

Contact Dr. Trabulsi

1025 Walnut Street
Suite 1112
Philadelphia, PA 19107

(215) 955-6961
(215) 923-1884 fax

Medical School
State University of New York at Buffalo, 1995

Residency
General Surgery, Thomas Jefferson University, 1997
Urology, Thomas Jefferson University, 2001

Fellowship
Fellow in Urologic Oncology, Memorial Sloan-Kettering Cancer Center, 2003
Fellow in Minimally Invasive Urologic Oncology, Memorial Sloan-Kettering Cancer Center, 2004

Board Certification
American Board of Urology, 2005

University Appointment
Associate Professor
Director of Minimally Invasive Urologic Oncology
Director of Clinical Trials
Director, Multidisciplinary Genito-Urinary Cancer Clinic, Kimmel Cancer Center
Co-Director, Jefferson Prostate Diagnostic Center

Hospital Appointment

Research and Clinical Interests
Dr. Trabulsi is Director of Minimally Invasive Urologic Oncology, as well as Director of Clinical Trials, in the Department of Urology, Jefferson Medical College at Thomas Jefferson University. He is also the Director of the Genito-Urinary Multidisciplinary Cancer Clinic, Kimmel Cancer Center at Jefferson.

Dr. Trabulsi's research and clinical interests include prostate cancer, kidney cancer, bladder cancer and testicular cancer. He is the author of numerous abstracts, manuscripts and book chapters.

Dr. Trabulsi focuses on all aspects of urologic oncology, including prostate cancer, bladder cancer, kidney cancer, testicular cancer.

Dr. Trabulsi performs minimally invasive urologic oncology procedures, including robotic-assisted laparoscopic radical prostatectomy, laparoscopic nephrectomy, laparoscopic partial nephrectomy, and laparoscopic cryosurgical ablation of kidney tumors.

Publications

Most recent Peer-reviewed Publications

  1. Targeted therapies in the management of metastatic bladder cancer
  2. Postprostatectomy radiation therapy: An evidence-based review
  3. Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer
  4. Minimally invasive radical prostatectomy: Transition from pure laparoscopic to robotic-assisted radical prostatectomy
  5. Post-prostatectomy image-guided radiation therapy: Evaluation of toxicity and inter-fraction variation using online cone-beam CT
  6. Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling
  7. Physician Beliefs and Practices for Adjuvant and Salvage Radiation Therapy After Prostatectomy
  8. Enhancing prostate cancer care through the multidisciplinary clinic approach: A 15-year experience
  9. Is there an optimal management for localized prostate cancer?
  10. Hormone therapy in the management of prostate cancer: Evidence-based approaches
  11. A phase i trial of samarium-153-lexidronam complex for treatment of clinically nonmetastatic high-risk prostate cancer: First report of a completed study
  12. Enhanced transrectal ultrasound modalities in the diagnosis of prostate cancer
  13. Preemptive multimodal pain regimen reduces opioid analgesia for patients undergoing robotic-assisted laparoscopic radical prostatectomy
  14. Reply by the authors
  15. Enhanced Transrectal Ultrasound Modalities in the Diagnosis of Prostate Cancer
  16. Thermal ablation of renal cell carcinoma: Triage, treatment, and follow-up
  17. Preemptive Multimodal Pain Regimen Reduces Opioid Analgesia for Patients Undergoing Robotic-Assisted Laparoscopic Radical Prostatectomy
  18. The quality-of-life impact of prostate cancer treatments
  19. A Phase I Trial of Samarium-153-Lexidronam Complex for Treatment of Clinically Nonmetastatic High-Risk Prostate Cancer: First Report of a Completed Study
  20. The Quality-of-Life Impact of Prostate Cancer Treatments

View All Publications